Novartis Ag (NVS) Enterprise Value (2017 - 2025)
Novartis Ag's Enterprise Value history spans 9 years, with the latest figure at -$11.7 billion for Q4 2025.
- For Q4 2025, Enterprise Value fell 161.07% year-over-year to -$11.7 billion; the TTM value through Dec 2025 reached -$11.7 billion, down 161.07%, while the annual FY2025 figure was -$11.7 billion, 161.07% down from the prior year.
- Enterprise Value for Q4 2025 was -$11.7 billion at Novartis Ag, down from -$4.5 billion in the prior quarter.
- Across five years, Enterprise Value topped out at -$4.5 billion in Q4 2024 and bottomed at -$28.3 billion in Q4 2021.
- The 5-year median for Enterprise Value is -$14.0 billion (2023), against an average of -$15.4 billion.
- The largest annual shift saw Enterprise Value surged 67.93% in 2024 before it tumbled 161.07% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$28.3 billion in 2021, then surged by 34.32% to -$18.6 billion in 2022, then increased by 24.96% to -$14.0 billion in 2023, then soared by 67.93% to -$4.5 billion in 2024, then crashed by 161.07% to -$11.7 billion in 2025.
- Per Business Quant, the three most recent readings for NVS's Enterprise Value are -$11.7 billion (Q4 2025), -$4.5 billion (Q4 2024), and -$14.0 billion (Q4 2023).